Renhe Pharmacy Co Ltd (SHE:000650) — Market Cap & Net Worth
Market Cap & Net Worth: Renhe Pharmacy Co Ltd (000650)
Renhe Pharmacy Co Ltd (SHE:000650) has a market capitalization of $1.17 Billion (CN¥7.97 Billion) as of May 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #8451 globally and #2182 in its home market, demonstrating a -0.87% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Renhe Pharmacy Co Ltd's stock price CN¥5.69 by its total outstanding shares 1399938234 (1.40 Billion). Analyse how efficiently does Renhe Pharmacy Co Ltd generate cash to see how efficiently the company converts income to cash.
Renhe Pharmacy Co Ltd Market Cap History: 2015 to 2026
Renhe Pharmacy Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.84 Billion to $1.17 Billion (-3.46% CAGR).
Renhe Pharmacy Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Renhe Pharmacy Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.29x
Renhe Pharmacy Co Ltd's market cap is 0.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.45x
Renhe Pharmacy Co Ltd's market cap is 2.45 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.84 Billion | $2.52 Billion | $391.30 Million | 0.73x | 4.69x |
| 2016 | $1.23 Billion | $3.57 Billion | $372.38 Million | 0.34x | 3.29x |
| 2017 | $920.97 Million | $3.84 Billion | $380.23 Million | 0.24x | 2.42x |
| 2018 | $985.86 Million | $4.40 Billion | $506.46 Million | 0.22x | 1.95x |
| 2019 | $1.15 Billion | $4.58 Billion | $537.83 Million | 0.25x | 2.14x |
| 2020 | $1.13 Billion | $4.28 Billion | $580.18 Million | 0.26x | 1.95x |
| 2021 | $1.76 Billion | $4.94 Billion | $665.02 Million | 0.36x | 2.65x |
| 2022 | $1.19 Billion | $5.15 Billion | $574.43 Million | 0.23x | 2.07x |
| 2023 | $1.31 Billion | $5.03 Billion | $567.26 Million | 0.26x | 2.32x |
| 2024 | $1.18 Billion | $4.07 Billion | $481.91 Million | 0.29x | 2.45x |
Competitor Companies of 000650 by Market Capitalization
Companies near Renhe Pharmacy Co Ltd in the global market cap rankings as of May 4, 2026.
Key companies related to Renhe Pharmacy Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.15 |
Renhe Pharmacy Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Renhe Pharmacy Co Ltd's market cap moved from $1.84 Billion to $ 1.17 Billion, with a yearly change of -3.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.17 Billion | +0.71% |
| 2025 | CN¥1.16 Billion | -1.91% |
| 2024 | CN¥1.18 Billion | -10.15% |
| 2023 | CN¥1.31 Billion | +10.53% |
| 2022 | CN¥1.19 Billion | -32.47% |
| 2021 | CN¥1.76 Billion | +55.45% |
| 2020 | CN¥1.13 Billion | -1.79% |
| 2019 | CN¥1.15 Billion | +16.89% |
| 2018 | CN¥985.86 Million | +7.05% |
| 2017 | CN¥920.97 Million | -24.83% |
| 2016 | CN¥1.23 Billion | -33.30% |
| 2015 | CN¥1.84 Billion | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Renhe Pharmacy Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.17 Billion USD |
| MoneyControl | $1.17 Billion USD |
| MarketWatch | $1.17 Billion USD |
| marketcap.company | $1.17 Billion USD |
| Reuters | $1.17 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Renhe Pharmacy Co Ltd
Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in … Read more